These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 2155079)

  • 1. Insensitivity of Tc-99m pertechnetate for detecting metastases of differentiated thyroid carcinoma.
    Campbell CM; Khafagi FA
    Clin Nucl Med; 1990 Jan; 15(1):1-4. PubMed ID: 2155079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of technetium-99m pertechnetate in postoperative thyroid carcinoma. A comparative study with iodine-131.
    Khammash NF; Halkar RK; Abdel-Dayem HM
    Clin Nucl Med; 1988 Jan; 13(1):17-22. PubMed ID: 2832116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m-pertechnetate scanning in metastatic thyroid carcinoma: a case report.
    Lamberigts G; De Roo M; Devos P; Burie D
    Clin Nucl Med; 1981 Apr; 6(4):172-4. PubMed ID: 7214773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m-pertechnetate whole-body SPET/CT scan in thyroidectomized differentiated thyroid cancer patients is a useful imaging modality in detecting remnant thyroid tissue, nodal and distant metastases before
    Lou K; Gu Y; Hu Y; Wang S; Shi H
    Hell J Nucl Med; 2018; 21(2):121-124. PubMed ID: 30089313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of iodine-131 and technetium-99m pertechnetate in thyroid carcinoma.
    Katagiri M; Suzuki S; Sadahiro S; Kubouchi K; Ohmura T; Tsumura O; Akatsuka S
    Clin Nucl Med; 1988 Apr; 13(4):276-9. PubMed ID: 2836118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative scintigraphic detection of cervical metastases from thyroid carcinoma with technetium-99m pertechnetate.
    Vieras F
    Clin Nucl Med; 1985 Aug; 10(8):567-9. PubMed ID: 2994934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
    Scott GC; Meier DA; Dickinson CZ
    J Nucl Med; 1995 Oct; 36(10):1843-5. PubMed ID: 7562053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of postoperative Tc-99m pertechnetate scintigraphy in estimation of remnant mass and prediction of successful ablation in patients with differentiated thyroid cancer.
    Ozdemir D; Cuhaci FN; Ozdemir E; Aydin C; Ersoy R; Turkolmez S; Cakir B
    Nucl Med Commun; 2016 Jun; 37(6):640-5. PubMed ID: 26895488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of technetium-99m pertechnetate in a patient with metastases of thyroid carcinoma.
    Yamamoto Y; Nishiyama Y; Ono Y; Satoh K; Ohkawa M; Kawasaki Y; Tanabe M
    Ann Nucl Med; 1999 Oct; 13(5):357-9. PubMed ID: 10582808
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Giovanella L; Paone G; Ruberto T; Ceriani L; Trimboli P
    Endocrinol Metab (Seoul); 2019 Mar; 34(1):63-69. PubMed ID: 30784242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of extrathyroidal uptake of Tc-99m and I-123 in the thyroid scan: concise communication.
    Ryo UY; Stachura ME; Schneider AB; Nichols R; Cogan SR; Pinsky S
    J Nucl Med; 1981 Dec; 22(12):1039-42. PubMed ID: 7310513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of extra-thyroid
    Long B; Yao LF; Chen SC; Shui J; Ye XM; Yi HQ; Lou C
    J Int Med Res; 2021 May; 49(5):3000605211012667. PubMed ID: 34024177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of metastatic thyroid carcinoma by 99mTc-pertechnetate in the presence of hyperfunctioning thyroid tissue.
    Krausz Y; Horne T
    J Surg Oncol; 1990 Jun; 44(2):132-4. PubMed ID: 2162453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative scintigraphic visualization of lymph nodes and pulmonary metastases from papillary thyroid carcinoma.
    Boughattas S; Hassine H; Arifa N; Chatti K; Degdegui M; Abdelkefi M; Essabbah H
    Ann Nucl Med; 2004 Feb; 18(1):59-62. PubMed ID: 15072185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic pure papillary thyroid carcinoma presenting as a toxic hot nodule.
    Cirillo RL; Pozderac RV; Caniano DA; Falko JM
    Clin Nucl Med; 1998 Jun; 23(6):345-9. PubMed ID: 9619317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary thyroid carcinoma concentrating both Tc-99m sodium pertechnetate and I-131 iodide. Case report and review of the literature.
    Tech KE; Davis L; Dworkin H
    Clin Nucl Med; 1991 Jul; 16(7):497-500. PubMed ID: 1657482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the neoplastic potential of solitary solid thyroid lesions with Tc-99m-pertechnetate and Tc-99m-sestamibi scanning.
    Wei JP; Burke GJ
    Ann Surg Oncol; 1995 May; 2(3):233-7. PubMed ID: 7641020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of papillary thyroid carcinoma and its metastatic lymph nodes. Images with Tc-99m pertechnetate, Tl-201, and Tc-99m sestamibi.
    Alper E; Akbunar T; Tamgac F
    Clin Nucl Med; 1996 Oct; 21(10):815-6. PubMed ID: 8896938
    [No Abstract]   [Full Text] [Related]  

  • 20. 99mTc-pertechnetate in the detection of thyroid carcinoma in a ten year period.
    Vorne M; Järvi K
    Eur J Nucl Med; 1987; 13(7):362-5. PubMed ID: 2828061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.